BillionToOne (BLLN) EV to EBITDA (2025 - 2026)

BillionToOne's (BLLN) quarterly EV to EBITDA came in at 921.25 in Q2 2026, up 431.31% quarter-over-quarter from 173.39 in Q1 2026.

Analysis

BillionToOne (BLLN) EV to EBITDA (2025 - 2026) Analysis & Trends

BillionToOne has disclosed EV to EBITDA across 2 years of filings, most recently posting 921.25 for Q2 2026.

In Q2 2026, EV to EBITDA changed N/A year-over-year to 921.25; the TTM figure through Jun 2026 stood at 117.08 (changed N/A YoY), while the FY2025 annual figure was 203.0, changed N/A from the prior year.
EV to EBITDA came in at 921.25 for Q2 2026 at BillionToOne, up from 173.39 in the prior quarter.
In the past five years, EV to EBITDA ranged from a high of 921.25 in Q2 2026 to a low of 173.39 in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Natera	47.13 Bn	46.03 Bn	486.15 Mn
2	Labcorp Holdings	26.44 Bn	26.32 Bn	1.11 Bn
3	Quest Diagnostics	26.16 Bn	25.84 Bn	1.03 Bn
4	Guardant Health	21.57 Bn	20.51 Bn	219.03 Mn
5	Tempus AI	11.32 Bn	10.51 Bn	274.25 Mn
6	Caris Life Sciences	7.08 Bn	6.29 Bn	182.38 Mn
7	Sotera Health	5.39 Bn	5.04 Bn	177.96 Mn
8	BillionToOne	4.65 Bn	4.11 Bn	77.11 Mn
9	iRhythm Holdings	4.05 Bn	3.46 Bn	163.21 Mn
10	Adaptive Biotechnologies	3.86 Bn	3.53 Bn	51.39 Mn

Historic Data

Download Data